Barsi, S., Papp, H., Valdeolivas, A., Tóth, D. J., Kuczmog, A., Madai, M., . . . Szalai, B. (2022). Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity. PLoS Computational Biology, 18(4), . https://doi.org/10.1371/journal.pcbi.1010021
Chicago-Zitierstil (17. Ausg.)Barsi, Szilvia, et al. "Computational Drug Repurposing Against SARS-CoV-2 Reveals Plasma Membrane Cholesterol Depletion as Key Factor of Antiviral Drug Activity." PLoS Computational Biology 18, no. 4 (2022). https://doi.org/10.1371/journal.pcbi.1010021.
MLA-Zitierstil (9. Ausg.)Barsi, Szilvia, et al. "Computational Drug Repurposing Against SARS-CoV-2 Reveals Plasma Membrane Cholesterol Depletion as Key Factor of Antiviral Drug Activity." PLoS Computational Biology, vol. 18, no. 4, 2022, https://doi.org/10.1371/journal.pcbi.1010021.